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The regulated transcription of a gene expressed in the 
immune system depends, as in any cell system, on contri- 
butions from multiple regulatory proteins and regulatory 
events. The existence of complex mechanisms of gene 
regulation was postulated many years ago (Gierer, 1973; 
Britten and Davidson, 1969; Georgiev, 1969) to explain 
how a genome of limited size can provide sufficient infor- 
mation for dictating an enormous number of expression 
patterns. The first installment of this review (Ernst and 
Smale, 1995) provided an overview of the multiple types 
of control regions and controlling events that contribute to 
the combinatorial regulation of transcription in eukaryotes. 
This installment focuses in greater detail on studies of 
the transcriptional regulation of a single gene, the murine 
immunoglobulin u (lgu) heavy chain gene. 
Transcriptional regulatory mechanisms have been stud- 
ied in greater detail for the lgp gene than for any other 
gene specific to the immune system (for detailed reviews, 
see Staudt and Lenardo, 1991; Nelsen and Sen, 1992; 
Kadesch, 1992; Calame and Ghosh, 1995). These studies 
have demonstrated that a diverse array of proteins are 
involved in lgp transcription. The identities of many of the 
regulatory proteins remain unknown and the precise regu- 
latory mechanisms have not been clearly established. 
However, the knowledge generated since lgu regulatory 
regions were first reported in 1963 has inspired several 
recent experiments that provide novel insights into regula- 
tory strategies. Following a brief introduction to the lgu 
gene as a model for B cell-specific transcription, specific 
experiments to illustrate these strategies are described. 
The expression of immunoglobulin genes is unique to, 
and essentially defines, the B cell lineage. The Igu locus 
appears to be activated at a very early stage of B cell 
development, preceding V(D)J recombination and possi- 
bly preceding commitment to the B cell lineage. The initial 
activation of the locus has been studied by analyzing 
changes in methylation status and DNase I hypersensitiv- 
ity of Igp regulatory regions (Mather and Perry, 1963; Storb 
et al., 1961). Hypomethylation and DNase I hypersensitiv- 
ity have been observed not only in B lineage cells, but 
also in multipotential hematopoietic precursors (Ford et 
al., 1992). Transcripts initiating within the locus are detect- 
able at an early progenitor B cell stage (Yancopoulos and 
Alt, 19651966). Following gene rearrangement (reviewed 
by Yancopoulos and Alt, 1966) mature transcripts in- 
crease throughout the subsequent preantigen recognition 
stages of differentiation (Perry and Kelley, 1979). lgu 
mRNA is further induced in an antigen- and T cell-depl 
dent manner (Melchers et al., 1980; Raynal et al., 19’ 
Yuan et al., 1992). 
The analysis of lgu transcription is complicated by 
gene rearrangements that take place in immature c 
and by the isotype switching events that take place 
mature cells. Some control elements may play a dual I 
of enhancing recombination/switching and transcripl 
initiation. Furthermore, in addition to the lgu enhancer 
scribed below, enhancers and locus control regions (LC 
are present downstream of the entire IgH locus and in 
vicinity of the coding segment for at least one other isot 
(see Calame and Ghosh, 1995; Madisen and Groudl 
1994; and references therein). For simplicity, we will fo 
our attention on the control regions needed for the B c 
specific transcription of a fully rearranged lgp gene. 
As shown in Figure 1, rearranged 1gf.r genes contai 
core promoter, regulatory promoter, enhancer, and mz 
attachment regions (MARS) that are typical for a mamma 
gene transcribed by RNA polymerase II (pol II; Staudt 
Lenardo, 1991; Calame and Ghosh, 1995). The core pror 
ers for the numerous Vk gene segments contain an AfT. 
sequence that appears to function as a TATA box by dir 
ing transcription initiation from a site located 25-3C 
downstream. The regulatory promoters are located prim, 
upstream of the TATA box. Although a few common c 
trol elements are found in the promoters of most VH g 
segments, the promoter sequences and control elemf 
vary. One element, called an octamer, is highly conser 
among the VH and V,. promoters and between spec 
Other conserved elements that influence promoter strer 
include a heptamer element 2-20 bp upstream of the 
tamer, as well as ClEBP and f.rE3 elements further 
stream (Figure 1). An enhancer of approximately 251 
is located in the J-Q intron and is flanked by two MA 
As described below, the intronic enhancer combined 1 
the MARS comprises an LCR. Control elements within 
enhancer include the CIEBP, uE1, f4E5, uE2, PA (01 
pE3, pB, pE4, and octamer elements. Proteins that h 
been shown to bind to these elements are indicate’ 
Figure 1. 
The control regions described above appear to be f 
cipally responsible for the precise expression level 
expression pattern observed with the endogenous 
arranged lgp gene. Rearranged murine lgu transger 
which include a Vn promoter, an intronic enhancer, 
MARS, are expressed at levels comparable to that of 
endogenous IgB gene (Grosschedl et al., 1984; Jenuv 
and Grosschedl, 1991). The murine transgenes also cla 
mimic the expression pattern of the endogenous gt 
both are expressed primarily in B cells and, in both ca: 
transcripts are detectable at low levels in a similar st 
other cell types (Jenuwein and Grosschedl, 1991; 1 
weiler et al., 1992). Furthermore, transcription from f.r 
hancer-containing transgenes and from the endogen 
Igu gene can be induced in vitro by differentiation 
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Figure 1. The Murine lmmunoglobulin p Heavy Chain Gene and Control Elements 
growth signals, such as interleukin-6 and lipopolysaccha- 
ride (Yuan et al., 1992; Raynal et al., 1969; Miller et al., 
1992). 
In the context of a rearranged gene, all of the control 
regions (core promoter, regulatory promoter, enhancer, 
and MARS) appear to be essential for efficient jr transcrip- 
tion in transgenic mice (Jenuwein and Grosschedl, 1991; 
Annweiler et al., 1992; Forrester et al., 1994). However, 
in transgenic mice or in transfection experiments, muta- 
tions in individual enhancer elements only partially reduce 
enhancer activity (Jenuwein and Grosschedl, 1991; Ann- 
weiler et al., 1992; Lenardo et al., 1967; Kiledjian et al., 
1966; Perez-Mutul et al., 1966; Tsao et al., 1966; Liber- 
mann et al., 1990; Nelsen et al., 1990, 1993). By using 
enhancer subfragments, instead of the entire enhancer, 
a more complete inhibition of activity can be obtained with 
a mutation in an individual enhancer element. 
B cell-specific transcription can be directed by either 
the promoter or the enhancer, if the promoter is accompa- 
nied by a heterologous enhancer or if the tr enhancer is 
accompanied by a heterologous promoter (Garcia et al., 
1966; Grosschedl and Baltimore, 1965). Thus, lgu tran- 
scription is regulated in a manner that appears to be redun- 
dant, in that no single control region or control element 
is solely responsible for B cell specificity. This concept is 
exemplified by the experiments described below, which 
reveal that several ubiquitous and cell-specific proteins 
contribute to the precise expression pattern of the lgu 
gene. 
A B Cell-Specific Coactivator Regulates 
Transcriptional Activation by Ott Proteins 
The octamer was the first regulatory element identified in 
the immunoglobulin heavy chain and light chain genes 
(for review, see Staudt and Lenardo, 1991). This element 
was conspicuous because of its conservation at a similar 
position (about 40 bp upstream of the TATA box) in almost 
all VH and VL promoters. In transfection assays and in 
transgenic mice, mutations in this element strongly reduce 
the activity of Vn and VL promoters. Furthermore, insertion 
of a single octamer element upstream of a simple core 
promoter generates a promoter that is selectively active 
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in 6 cells. A control element matching the octamer motif is 
also present in the lgp enhancer; mutation of this octamer 
element reduces, but does not eliminate, tissue-specific 
enhancer activity in transgenic mice (Jenuwein and Gross- 
chedl, 1991; Annweiler et al., 1992). These and other re- 
sults (Staudt and Lenardo, 1991) demonstrate that the 
octamer element plays a critical role in regulating the B 
cell specificity of lgp transcription. 
Electrophoretic mobility shift assays led to the identifica- 
tion of multiple proteins that interact with the octamer motif 
(Singh et al., 1986; Staudt et al., 1986; Landolfi et al., 
1986). Isolation of cDNAs encoding these proteins re- 
vealed that they are members of a large class of DNA- 
binding proteins referred to as the POU domain proteins 
(Herr et al., 1988; Rosenfeld, 1991; Schdler, 1991). The 
POU domain, which is approximately 150 aa in length, 
consists of two adjacent regions that are homologous 
among family members: the POU-specific domain and the 
POU-homeo domain. Both of these regions contain helix- 
turn-helix motifs that are required for high affinity DNA 
binding. Numerous POU domain proteins have been iden- 
tified, many of which are expressed in a cell type-specific 
manner (Rosenfeld, 1991; Schbler, 1991). Not surpris- 
ingly, numerous genes with widely varying expression pat- 
terns contain binding sites for these proteins, with many of 
the binding sitesclosely resembling the octamer elements 
found in the immunoglobulin genes. 
Ott-1 and Ott-2 are two POU domain proteins that have 
been characterized extensively and bind with high affinity 
to the octamer elements in the immunoglobulin genes 
(Staudt and Lenardo, 1991). These proteins are encoded 
by two different genes, but the Ott-2 transcripts undergo 
alternative splicing, resulting in the production of several 
distinct protein isoforms (Wirth et al., 1991). These iso- 
forms contain the same POU domain, but the surrounding 
sequences differ, leading tovariable transcriptional activa- 
tion properties (Annweiler et al., 1994). Ott-1 and Ott-2 
appear to bind equally well to the immunoglobulin octamer 
motif, but Ott-1 is expressed in most cell types, whereas 
Ott-2 is expressed primarily in B cells (Staudt and Lenar- 
do, 1991). 
The identification of an Ott protein that is expressed 
primarily in B cells suggests a simple model: only Ott-2 
can function through the immunoglobulin octamer ele- 
ments, thereby leading to the B ceil specificity of immuno- 
globulin transcription. Recently, however, this model has 
been disproven, as homozygous disruption of the Ott-2 
gene did not reduce immunoglobulin expression in mice 
or in cultured B cells (Corcoran et al., 1993; Feldhaus et 
al., 1993). Instead, Ott-2 appears to be essential primarily 
for events that occur during terminal differentiation of B 
cells (Corcoran et al., 1993; Corcoran and Karvelas, 1994; 
Radomska et al., 1994). Consistent with these results are 
several studies that have demonstrated equally efficient 
transcriptional activation of immunoglobulin promoters by 
both Ott-1 and Ott-2 (LeBowitz et al., 1988; Pierani et al., 
1990; Pfisterer et al., 1994; and references therein). With 
an in vitro transcription assay, for example, an immuno- 
globulin promoter was strongly activated by either purified 
Ott-1 or purified Ott-2 in a B cell nuclear extract depleted 
of Ott proteins (Pierani et al., 1990). Thus, the ubiquita 
Ott-1 protein appears to be perfectly capable of activati 
transcription through a control element that imparts B c 
specificity to an immunoglobulin promoter. 
An attractive explanation for the above results h 
emerged from studies performed both in vitro and in vi\ 
Extending the in vitro results described above, Pierani 
al. (1990) found that neither Ott-1 nor Ott-2 could e 
ciently activate transcription from an immunoglobulin p 
moter in a nonlymphoid (HeLa) cell extract, even thou 
both proteins strongly activated transcription from a t 
tone H2B promoter, which contains a similar octamer f 
ment. Similar results were found in vivo, most recently 
Pfisterer et al. (1994), who stably expressed various Oc 
isoforms in fibroblast cell lines at levels comparable to 1 
Ott-2 levels in B cells. Despite the presence of signific; 
Ott-2 protein i? the transfected fibroblasts, synthetic p 
moters under the control of multiple octamer eleme 
were inactive. These observations suggest that a disti 
B cell-restricted activity may be required for immunogll 
ulin transcriptional activation by both Ott-1 and OctC 
A novel activity that appears to be responsible for 
above results has been defined as a B cell-restricted 
activator, called OCA-B (Pierani et al., 1990; Luo et 
1992; Luo and Roeder, 1995). In general, two biochemi 
activities have been attributed to OCA-B. When addec 
a HeLa cell extract, it facilitates transcriptional activat 
of an immunoglobulin promoter (but not an H2B promo 
by either Ott-1 or Ott-2. In addition, OCA-B physic 
associates with both Ott-1 and Ott-2, but not with anot 
Ott protein, Ott-3. Purified OCA-B preparations con1 
two protein species with molecular masses of 34 and 
kDa (Luo and Roeder, 1995). From partial amino acid 
quences of the purified proteins, acDNA has been isola 
that encodes both proteins, with the 35 kDa protein apl 
ently derived by posttranslational modification (Luo i 
Roeder, 1995). Antibodies directed against the recon 
nant protein inhibit OCA-B-mediated activation of an 
munoglobulin promoter, confirming that the isolated CD 
encodes the OCA-B activity. Interestingly, the OCA-6 g( 
was independently isolated by two other laboratories fl 
cDNA expression libraries screened for proteins thai 
rectly bind to Ott-1 or Ott-2 (Gstaiger et al., 1995; Strl 
et al., 1995). 
The properties of the OCA-B coactivator descri 
above provides an explanation for the B cell specif 
attributed to the octamer elements of immunoglobulin 
moters. At the same time, several new questions eme 
Principally, why is a specific coactivator needed for t 
scription from immunoglobulin promoters, but appare 
not for transcription from other promoters that can be i 
vated by Ott-1, like the H2B promoter? The specif 
does not appear to reside in the immunoglobulin pro1 
ers, as synthetic promoters containing octamer eleml 
also exhibit B cell specificity (Pfisterer et al., 1994, 
references therein). One simple explanation may be 
the spacing between the octamer and the TATA bc 
shorter in the vertebrate H2B promoters than in the irr 
noglobulin promoters (Luo et al., 1992); the shot-l spa 
could allow Ott-1 to function in the absence of a coat 
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tar. An alternative explanation is that, in the H2B genes, 
Ott-1 may act in concert with another protein that binds 
to the promoter. Utilizing recombinant coactivator and Ott 
proteins, this and other questions regarding the mecha- 
nisms of activation through octamer elements can now be 
addressed. 
Interplay Between Positive and Negative 
Regulators at the pE Elements 
The studies described above demonstrate that ubiquitous 
Ott proteins contribute to the B cell specificity of igu tran- 
scription by employing a tissue-restricted coactivator. This 
section describes studies of another family of transcription 
factors, the bHLH proteins, which provide further insight 
into the mechanisms by which ubiquitous proteins may 
influence lgu regulation. Two related questions are ad- 
dressed by these studies: how do ubiquitous bHLH pro- 
teins regulate B cell-specific transcription? If bHLH family 
members with the capability of binding to u enhancer ele- 
ments are present in nonlymphoid cells, why is the lgu 
gene inactive in these cells? 
Proteins of the bHLH family recognize the uE elements 
within the u enhancer (Kadesch, 1992; Murre et al., 1994; 
Calame and Ghosh, 1995). The bHLH domain that is char- 
acteristic of this family contains a stretch of basic amino 
acids followed by two amphipathic helices that are sepa- 
rated by a spacer (i.e., loop). The bHLH proteins bind to 
DNA as heterodimers with other family members or, in 
some cases, as homodimers; the basic region mediates 
the protein-DNA interactions and hydrophobic surfaces 
of the HLH domain mediate dimerization. A core binding 
sequence for bHLH dimers is CANNTG, with the two cen- 
tral nucleotides and flanking nucleotides involved in de- 
termining the precise binding specificity for a homodimer 
or heterodimer. Although considerable effort has been ap- 
plied towards isolating a bHLH protein that is expressed 
specifically in lymphocytes, none has been found. Instead, 
the bHLH proteins expressed in lymphocytes appear to 
be expressed in many cell types. 
Two general classes of bHLH proteins bind to the uE 
elements in lymphocytes. One class includes protein prod- 
uctsof the E2A, E2-2, and HEBgenes(Murre et al., 1989a; 
Henthorn et al., 1990; Hu et al., 1992). The proteins in 
this class are capable of binding to the uE2, uE4, and uE5 
elements as homodimers or as heterodimers. The E2A 
gene produces three protein products through alternative 
splicing: E12, E47, and E2-5. Most studies described be- 
low have employed the protein isoforms derived from the 
E2A gene. We will not distinguish between these isoforms 
for simplicity and because it is not yet clear which products 
actually function through each control element. 
The second class of bHLH proteins that interacts with 
the u enhancer contains several members, including 
TFE3, TFEB, and USF (Calame and Ghosh, 1995; Beck- 
mann et al., 1990; Carr and Sharp, 1990; Gregor et al., 
1990; Roman et al., 1992). Members of this class bind as 
homodimers, or as heterodimers with each other, to the 
uE3 element in the enhancer and to uE elements found 
in some IgH promoters (Artandi et al., 1994). A unique feature 
of this family is the presence of a leucine zipper (Kerppola 
and Curran, 1991) as a second protein-protein interaction 
motif, C terminal to the bHLH domain. In this family, which 
is sometimes referred to as the bHLH-ZIP family, the zip- 
per domain appears to be a primary determinant of the 
dimerization specificity (Beckmann and Kadesch, 1991; 
Fisher et al., 1991; Roman et al., 1992). The presence of 
two protein-protein interaction motifs makes it possible 
for the bHLH-ZIP proteins to form higher order multimers; 
in fact, tetramers of the TFE3 and USF proteins have been 
identified (Ferre-D’Amare et al., 1994; Artandi et al., 1994). 
This finding suggests that bHLH-ZIP tetramers, by bind- 
ing simultaneouslyto PIE elements in both the lgu promoter 
and lgu enhancer, may provide a physical bridge between 
the two control regions. Support for this idea recently has 
been provided by experiments that demonstrate that TFE3 
possesses a fairly unique ability to stimulate transcription 
from a distant enhancer site in a manner that is absolutely 
dependent on the presence of TFE3 binding sites in the 
promoter (Artandi et al., 1994). 
Despite the apparent absence of a lymphocyte-specific 
bHLH protein, considerable evidence suggests that prod- 
ucts of this family directly participate in B cell-specific lgu 
transcription. The first evidence for this role was provided 
by in vivo genomic footprinting experiments, which re- 
vealed protein-DNA contacts at the uE motifs in B cells 
but not in nonlymphoid cells (Ephrussi et al., 1985; Church 
et al., 1985). More recently, overexpression of an E2A 
protein was found to activate rearrangement and tran- 
scription of the endogenous lgu gene in a progenitor T cell 
line (Schlisselet al., 1991). Furthermore, mice containing a 
homozygous disruption of the E2A gene specifically lack 
progenitor and mature B cells (Bain et al., 1994; Zhuang 
et al., 1994). Together, these results suggest that E2A 
proteins, and possibly other bHLH proteins, play major 
roles in regulating the B cell specificity of lgu transcription. 
Electrophoretic mobility shift assays performed with nu- 
clear extracts provided a clue as to the mechanism by 
which ubiquitous bHLH proteins might direct cell-specific 
transcription, by revealing the formation of B cell-specific 
protein-DNA complexes with DNA probes containing uE2, 
uE4, or uE5 (Murre et al., 1991; Bain et al., 1993; Jacobs 
et al., 1993). The presence of E2A proteins within these 
complexes was demonstrated by their reactivity with 
monoclonal antibodies. Further characterization of the 
complexes suggested that they include E2A or E2-2 
homodimers or heterodimers. The molecular mechanism 
responsible for the B cell-specific dimerization of ubiqui- 
tous proteins has not been established, but four possible 
mechanisms (which are not mutually exclusive) have been 
proposed. First, a posttranslational modification of the 
ubiquitous proteins could regulate the formation of B cell- 
specific dimers. Second, the formation of an intermolecu- 
lar disulfide bond, which has been identified in E2A ho- 
modimers, may be regulated in a B cell-specific manner 
(Benezra, 1994). Third, preferential heterodimer formation 
with cell-specific bHLH proteins could prevent the ubiqui- 
tous proteins from forming dimers with each other in non-B 
cells. In muscle cells, for example, E2A proteins preferen- 
tially form heterodimers with muscle-specific bHLH pro- 
teins like MyoD (Murre et al., 1989b; Lassar et al., 1991). 
A fourth mechanism for preventing the dimerization of 
ubiquitous bHLH proteins with each other is through se- 
questration by HLH proteins that are dedicated to thisfunc- 
tion. Two such proteins are Id and Id2 (Benezra et al., 
1990; Sun et al., 1991). Both of these proteins contain 
HLH domains that are homologous to the HLH domains 
of E2A proteins, but the Id proteins lack a basic domain. 
Therefore, although Id and Id2 form heterodimers with the 
E2A proteins, the heterodimers are not capable of binding 
to DNA. The Id proteins were first implicated in lgp tran- 
scription and B cell development by the observation that 
both Id and id2 are expressed at high levels in progenitor 
B cell lines that lack detectable lgw transcription, but are 
not expressed in more mature B cells (Wilson et al., 1991; 
Sun et al., 1991). Furthermore, ectopic expression of Id 
in cultured cells led to repression of the u enhancer, pre- 
sumably by forming dimers with E2A proteins (Wilson et 
al., 1991). Recently, constitutive expression of Id in the B 
cell lineage of a transgenic mouse was found to block B 
cell development at an early stage (Sun, 1994). Although 
these studies primarily confirm that the heterodimer part- 
ners of Id are required for B cell development, the results 
are intriguing and consistent with the idea that Id proteins 
may play a direct role in regulating lgp transcription. 
Although E2A homodimers appear to form only in B 
cells, it has been well established that E2A proteins form 
potent transcriptional activators in other cell types as het- 
erodimers with cell-specific proteins like the muscle-spe- 
cific MyoD protein (Lassar et al., 1991). In fact, a subset 
of the uE sequences are identical to the E boxes found 
in muscle-specific genes, which are strongly activated by 
MyoDIE2A heterodimers (Lassar et al., 1991; Weintraub 
et al., 1994). This observation highlights the critical ques- 
tion of why these heterodimers do not activate lgu tran- 
scription in muscle cells. Clearly, the lack of B cell- 
restricted proteins like OCA-B and PU.1 (see below) in 
muscle cells helps to prevent efficient lgp transcription. 
However, recent experiments have suggested that a more 
direct strategy has evolved to insure that lgb transcription 
is not induced in non-B cells. This strategy involves nega- 
tive regulation through the pE4 and uE5 elements. 
The bE4 element was implicated in negative regulation 
through the analysis of B x T hybrid cell lines (Shen et 
al., 1993). In these hybrids, transcription of the endoge- 
nous lgp gene is repressed, presumably because trans- 
acting repressors expressed by the T cell partner interfere 
with activators expressed by the B cell partner. By trans- 
fecting the hybrids with reporter genes under the control 
of various f.r enhancer fragments and mutant enhancers, 
the t1E4 element was found to contribute to enhancer re- 
pression (Shen et al., 1993). The wE5 element was impli- 
cated in negative regulation through analysesof enhancer 
mutants in nonlymphoid cells. In cultured cell lines and 
in transgenic mice, mutation of the pE5 element led to 
enhancer activity in multiple cell types (Kadesch et al., 
1986; Wasylyk and Wasylyk, 1986; Weinberger et al., 
1988; Ruezinsky et al., 1991; Ft. Grosschedl, personal 
communication). 
The negative effects observed with the )1E4 and FEN 
elements suggest that they interact with a repressor that 
prevents adjacent control elements (e.g., bE2 and u 
from functioning in non-B cells. Indeed, a candidate 
this repressor protein, which binds to both t~E4 and t.r 
recently has been isolated (Genetta et al., 1994). This l 
tein, called ZEB, contains a zinc finger DNA binding 
main and is expressed ubiquitously. E2A homodimers’ 
displace ZEB from the pE5 element, but ZEB overexpi 
sion cannot repress the u enhancer in B cells. This re 
suggests that ZEB and E2A proteins do not carry OI 
simple competition for the pE5 site. 
The above studies suggest that the uE4 and pE5 
ments contribute to the B cell specificity of lgu transc 
tion at three distinct levels. First, they interact with % 
pressor that directly inhibits the binding of bHLH din 
in non-B cells. Second, they serve as binding sites for I 
homodimers, which displace the repressor and contrit 
to transcriptional activation in B cells. Third, repre: 
binding to the pE4 and wE5 elements in non-B cells ir 
feres with transcriptional activation through surrounc 
enhancer elements. A detailed analysis of this third fr 
tion for the uE5 element recently was reported by W 
traub et al. (1994). The goal of the study was to detern 
why MyoDIE2A heterodimers do not activate the w 
hancer in muscle cells, even though the heterodimers I 
tightly to PE elements in vitro. The initial observation 
transient assay in fibroblasts was that transfection 
MyoD expression plasmid led to strong transcriptional i 
vation of a cotransfected reporter gene under the COI 
of E box multimers from a muscle-specific gene, bul 
of a reporter gene under the control of multimers 
p enhancer fragment containing the pE5, uE2, and 
elements. In contrast, transfection of an E2A expres 
plasmid led to strong activation of both reporters. Anal 
of mutations in each of the three BE elements reve, 
that pE5 was responsible for the inability of MyoD to 
vate the reporter containing pE5-uE3+E2 multimerz 
MyoD strongly activated a reporter gene under the COI 
of pE5 mutant+E3-PEP multimers. These results con 
that uE5 plays a role in negative regulation and den 
strate that the putative repressor influences MyoD tr 
activation, but not E2A transactivation. 
The ability of E2A homodimers to displace the puti 
repressor was confirmed by coexpression of MyoD 
an E2A mutant containing its bHLH domain but lac 
its transcriptional activation domains (Weintraub ei 
1994). In the presence of the coexpressed E2A bHLF 
main, MyoD strongly transactivated the pE5-pE3-pE 
porter, presumably because the E2A bHLH homodir 
displaced the repressor from the pE5 element, allot 
MyoD-containing dimers to activate through the othe 
elements. Detailed characterization of the PEB-depen 
repression revealed that it is specific to bHLH protc 
as the pE5 element could not repress transcription Y 
placed adjacent to binding sites for other activators. N 
over, the ability of the pE5 element to repress transcrif 
was dependent on only 4 bp flanking the core E bo: 
quence, as a 4 bp mutation converted the pE5 eler 
from a repression element into a MyoD-responsive ac 
tion element. Equally subtle characteristicsof the E2A 
teins were involved in repressor displacement, sincl 
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placement of two amino acids in the basic domain of an 
E2A protein with two amino acids from MyoD strongly re- 
duced the ability of E2A to displace the t.4E5 repressor. In 
other words, highly specific sequence differences be- 
tween bHLH proteins and their binding sites appear to be 
responsible for dramatic functional differences. 
To summarize, the PE elements and ubiquitous E2A 
proteins (and possibly other ubiquitous bHLH proteins) 
contribute to B cell-specific 1gt.r transcription through a 
variety of mechanisms. In nonlymphoid cells, E2A homodi- 
mers do not form. In addition, ZEB or ZEB-like repressor 
proteins bind to pE5 and pE4 and prevent ubiquitous en- 
hancer-binding proteins from stimulating enhancer activ- 
ity. In lymphoid cells, E2A homodimers bind to the pE4 
or pE5 elements, or both, and contribute to enhancerfunc- 
tion through their transcriptional activation domains. The 
E2A proteins also displace the ZEB or ZEB-like repressors 
from the uE4 and pE5 elements, allowing bHLH proteins 
to stimulate transcription from the nearby uE2 and uE3 
elements, through functional cooperation with the tissue- 
restricted PA- and BB-binding proteins described in the 
next section. 
Context-Dependent Activation Through 
the pA, pE3, and pB Elements 
The studies of Ott and bHLH proteins have elucidated 
mechanisms employed by ubiquitously expressed pro- 
teins to influence the B cell specificity of IgB transcription. 
Moreover, the detailed analysis of the pE5 and r~E4 ele- 
ments has revealed the critical interplay between positive 
and negative regulation. This section describes studies of 
a third family of DNA-binding proteins, the Ets family, 
whose cell type-restricted expression patterns contribute 
to B cell-specific lgu transcription. These studies demon- 
strate that the activity of a transcription factor can depend 
strongly on the context of its binding site; in other words, 
a transcription factor may be nonfunctional or may function 
aberrantly unless bound at a specific location relative to 
other DNA-binding proteins. In addition, these studies 
highlight a basic principle of combinatorial gene regula- 
tion: that B cell specificity may be generated by two pro- 
teins that both are expressed in multiple cell types, if their 
expression patterns overlap only in the B cell lineage. 
Mutational studies of the entire p enhancer and of en- 
hancer fragments have revealed that the uA (or A) and 
uB elements, as well as the intervening pE3 element, are 
needed for optimal enhancer activity in B cells (Nelsen et 
al., 1990, 1993; Libermann et al., 1990; Libermann and 
Baltimore, 1993; Rivera et al., 1993). A member of the Ets 
family, called PU. 1, binds tightly to the IJB element (Nelsen 
et al., 1993) and several other Ets family members bind 
to the PA element (Nelsen et al., 1993; Riveraet al., 1993; 
Lopez et al., 1994). The prototypic member of the Ets fam- 
ily of DNA-binding proteins is c-Ets-1, which is the cellular 
homologue of the E26 avian retrovirus v-Ets protein (for 
review, see Wasylyk et al., 1993). Members of this family 
range from highly tissue-restricted proteins to ubiquitously 
expressed proteins. The Ets family members contain a 
homologous 64 aa domain that interacts as a monomer 
with DNA sequences containing a GGA or GGAA core. 
Sequences surrounding this core determine the precise 
sequence specificities of the many family members, but, 
in general, multiple Ets family members will bind in vitro 
to any given GGA-containing control element. For exam- 
ple, at least five different Ets family members are capable 
of binding to the uA element, presumably with varying 
affinities (Nelsen et al., 1993; Rivera et al., 1993; Lopez 
et al., 1994). The structure of the Ets domain has recently 
been solved by multidimensional nuclear magnetic reso- 
nance, revealing a new type of helix-turn-helix motif 
(Liang et al., 1994). 
A common characteristic of many Ets family members 
is that they appear to activate transcription poorly by them- 
selves, but instead function cooperatively with other pro- 
teins (Wasylyk et al., 1993). PU.l provides one example 
of this characteristic. When multimers of the PB element 
were inserted upstream of a simple promoter and reporter 
gene, only weak promoter activity was observed following 
transfection into B cell lines that contain high levels of 
PU.l (Nelsen et al., 1993). Furthermore, overexpression 
of PU.l did not strongly stimulate transcription through 
the uB element (Nelson et al., 1993). These results con- 
trast with those obtained with some of the Ott and bHLH 
proteins, which efficiently activated transcription when 
multiple binding sites for the proteins were inserted into 
a reporter plasmid and tested in a transient transfection 
assay. The weak activity detected with j.tB multimers sug- 
gests that PU.l does not possess a strong transcriptional 
activation domain that is capable of independently en- 
hancing transcription initiation. In fact, a transcriptional 
activation domain has been identified at the N terminus 
of the PU.l protein (Hagemeier et al., 1993; Shin and 
Koshland, 1993) but this domain only weakly activates 
transcription of reporter plasmids containing multiple PU.l 
binding sites. 
In the u enhancer, efficient transcriptional activation by 
PU.l through the j.rB element depends on the presence 
of the adjacent PA and pE3 elements. When a reporter 
gene under the control of two copies of a fragment con- 
taining these three elements was tested by transient trans- 
fection in a B cell line, strong enhancer activity was de- 
tected (Nelsen et al., 1993). Mutation of any of the three 
elements abolished activity. Thus, this control region ap- 
pears to depend on functional interactions between three 
proteins. 
Transient transfection experiments in fibroblasts sug- 
gest that the enhancer activity of this tripartite fragment 
depends on Ets-1 bound to IA, PU.l bound to uB, and 
TFE3 bound to t~E3. In fibroblasts, cotransfection of either 
an Ets-1 expression plasmid or a PU.l expression plasmid 
with the reporter plasmid resulted in only weak activation 
(Nelsen et al., 1993). However, cotransfection of both of 
these expression plasmids with the reporter plasmid led 
to strong activation (Nelsen et al., 1993). Although the 
~1E3 element was required for efficient activation in these 
experiments, ectopic expression of a bHLH was not 
needed, presumably because the functional pE9binding 
protein is present in fibroblasts. 
Evidence in support of TFE3 as the functional uE3- 
binding protein has been derived from coexpression ex- 
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periments, which showed that TFE3 can cooperate with 
either PU.l or Ets-1 for transcriptional activation (Ft. Sen, 
personal communication). In particular, with a reporter 
gene under the control of the pA-uE3-ttB fragment, over- 
expression of anyone protein, Ets-1 , TFE3, or PU.1, failed 
to activate transcription significantly in fibroblasts. How- 
ever, simultaneous overexpression of any two proteins, 
Ets-1 and TFE3, PU.l and TFE3, or Ets-1 and PU.l, led 
to strong activation. These results suggest that when TFE3 
is overexpressed, it can functionally cooperate with either 
PU.l or Ets-1 during transcriptional activation. However, 
when lower (endogenous) concentrations of TFE3 are 
present, activity of the uA-wE3-pB fragment depends on 
both Ets-1 and PU.l, in addition to TFE3. These results 
suggest that both Ets-1 and PU.l may be capable of re- 
cruiting TFE3 to the enhancer; depending on whether high 
or normal concentrations of TFE3 are present within the 
cell, one or both of the Ets family proteins may be needed 
for efficient recruitment. 
The precise mechanism by which Ets-1 , TFE3, and PU.l 
cooperate with each other during transcriptional activation 
remains unknown. However, insight into this issue has 
been provided by studies of the protein domains required 
for activity. For each of the three proteins, discrete do- 
mains have been defined that are needed for transcrip- 
tional activation of a reporter gene under the control of 
multiple copies of the binding site of that protein (Hage- 
meier et al., 1993; Shin and Koshland, 1993; Schneikert 
et al., 1992; Beckmann et al., 1990). Most likely, these 
domains lead to transcriptional activation by communicat- 
ing directly with the general transcription machinery or 
with acoactivator. Interestingly, for activity of the pA+E3- 
PB fragment, the transcriptional activation domain of Ets-1 
is required, but only the DNA-binding domain of PU.l is 
needed (R. Sen, personal communication; the TFE3 do- 
mains required for activity of the t1A-uE3-pB fragment 
have not been determined). One possible explanation for 
this result is that the primary role of PU.l is to help recruit 
TFE3, Ets-1 , or both to the enhancer. The PU.l DNA bind- 
ing domain could carry out this role either through direct 
protein-protein interactions with TFE3 or Ets-1 or through 
an indirect mechanism (e.g., by preventing the binding of 
nucleosomal or repressor proteins). The requirement for 
the transcriptional activation domain of Ets-1 and possibly 
of TFE3 suggests that these proteins may be responsible 
for communicating with general transcription factors. The 
activation domains of Ets-1 and TFE3 may function inde- 
pendently, possibly by interacting with different general 
factors or coactivators, or may function together by form- 
ing a composite activation domain; either of these mecha- 
nisms could lead to cooperative, or synergistic, activation. 
To summarize, the functional cooperativity between Ets-1 , 
TFES, and PU.l may result from cooperative DNA binding, 
cooperative transcriptional activation, or a combination of 
the two. 
The studies described above reveal specific functional 
interactions between Ets-1 , TFE3, and PU.l. These pro- 
teins and interactions may be critical for activity of the 
p enhancer. However, it should be stressed that these 
experiments, like most of the experiments presented with 
the octamer and uE elements, were not performed in 1 
context of the entire enhancer. Moreover, an exhaust 
analysis of all Ets family and bHLH family members H 
not carried out, making it possible that other members 
these families may function similarly with the PA-pE3- 
fragment or, more importantly, may function preferentii 
in the context of the endogenous f.r gene. In supporl 
this possibility, studies of the f.tA element by itself or n 
the adjacent uE2 element, have suggested that other 
family members, including Fli-1, Erg-3, or ERP, may c 
tribute to enhancer activity (Rivera et al., 1993; Lope; 
al., 1994). Further experiments will be needed to de 
mine whether only one Ets family member is capabk 
carrying out the precise protein-protein interactions 
quired for WA function; whether multiple Ets family mc 
bers have evolved to function through VA, providing a 
gree of redundancy; or whether the multiple Ets far 
members function through PA at distinct stages of de1 
opment. Similar possibilities exist for the multiple bHL 
ZIP proteins that bind to the pE3 element, as well as 
the multiple Ott proteins that bind to the octamer eleme 
and the multiple bHLH proteins that bind to the pE2, u 
and uE5 elements. 
The cooperative interactions between Ets-1 , TFE3, i 
PU.l appear to contribute to the B cell specificity of 
transcription, based on the finding that the t~A-pE3- 
fragment functions in B cells, but not in other cell ty 
that have been tested (Nelsen et al., 1993). Reminisc 
of the Ott and ~E5-uE4 examples, none of the functic 
DNA-binding proteins appear to be expressed exclusil 
in B cells. In the previous examples, B cell specificity rs 
on a B cell-specific coactivator or on B cell-specific din 
ization. In this case, the B cell specificity results from 
overlapping expression patterns of DNA-binding protc 
that function cooperatively. PU.l is expressed prim; 
in the Bcell and myeloid lineages, and possibly in hem 
poietic progenitors (Wasylyk et al., 1993; Scott et 
1994). Ets-1 is expressed in B and T cells and in a var 
of other cell types (Wasylyk et al., 1993). With the I 
kE3-pB fragment, neither protein functions independe 
preventing significant activation in T cells by Ets-1, 
example. The expression patternsof the two proteinso 
lap primarily in B cells, resulting in considerable B 
specificity of the enhancer fragment. Most likely, a 
tional functional cooperativity with other u promoter 
enhancer fragments, like the octamer and pECuE4 
ments, results in the creation of a highly restricted exe 
sion pattern. 
Regulation of Chromatin Structure at the Igp Lot 
The studies described in the preceding sections sug 
that 1gt.r transcription is regulated by a complex arrE 
ubiquitous and cell-specific proteins that are capabl 
binding to promoter and enhancer elements. These 
teins are likely to interact with each other and, with 
help of coactivators, to regulate the formation of a 
II-containing preinitiation complex at the transcription 
site. Thus far, however, we have described these prot 
protein and protein-DNA interactions as they might o 
on a naked DNA template. In fact, the lgcl locus most I 
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is assembled into an inaccessible chromatin configuration 
prior to gene activation (Jenuwein et al., 1993; Forrester 
et al., 1994). Although the structure of the inaccessible 
chromatin remains undefined, it may be in the form of a 
30 nm filament (see Ernst and Smale, 1995). 
During B cell development, changes in chromatin struc- 
ture within the 1gf.r locus occur prior to or concomitant with 
the activation of gene rearrangement and transcription 
initiation (Ford et al., 1992). Two recent studies by 
Grosschedl and colleagues (Jenuwein et al. 1993; Forres- 
ter et al., 1994) have suggested that the intronic enhancer 
and its flanking MARS (Cockerill et al., 1987) are largely 
responsible for inducing these chromatin alterations. 
These studies characterized transcription and chromatin 
structure in mice containing rearranged Igu transgenes. 
The transgenes contained the entire intronic enhancer or 
enhancer fragments in the presence or absence of the 
flanking MARS. 
In the transgenic mice, efficient, position-independent 
transcription from a VH promoter within the transgene was 
detected when both the enhancer and MARS were included, 
but not when either of these regions was deleted. Chroma- 
tin accessibility throughout the locus, as measured by 
DNase I sensitivity, was similarly dependent on both the 
enhancer and MARS. These results suggest that the com- 
bination of the intronic enhancerand the MARS issuff icient 
for inducing locus accessibility and position-independent 
lgu transcription, functions that define an LCR. 
One limitation of the above experiments is that they do 
not establish whether the enhancer and MARS are directly 
responsible for the chromatin alterations, or whether the 
chromatin alterations are the result of transcription initia- 
tion and elongation by pol II. To distinguish between these 
possibilities, Jenuwein et al. (1993) measured chromatin 
accessibility with transgenes that link a bacteriophage T7 
promoter instead of a pol II promoter to the enhancer/ 
MARS. Pre-B cell lines derived from the mice were then 
tested for locus accessibility by adding T7 RNA polymer- 
ase to isolated nuclei. This elegant strategy uncoupled 
the enhancer from transcription, thereby ruling out the 
possibility that the enhancer influences chromatin struc- 
ture only as a result of transcriptional enhancement. In 
addition, the measurement of T7 transcripts provided an 
assay that was more specific and more quantitative than 
DNase I for measuring chromatin accessibility. The results 
confirmed that, indeed, the intronic enhancer and flanking 
MARS could induce accessibility of the DNA to T7 RNA 
polymerase, regardless of whether the T7 promoter was 
close to or at a distance of 1 kb from the enhancer. 
A similar set of experiments was performed with trans- 
genes containing the intronic enhancer in the absence of 
the MARS (Jenuwein et al., 1993; Forrester et al., 1994). 
The enhancer could not stimulate transcription initiation 
from the VH promoter, but was capable of inducing chroma- 
tin alterations in the local vicinity of the enhancer. In fact, 
a 95 bp fragment of the enhancer (which lacks the pE4 
and octamer elements) was sufficient for inducing local 
access to T7 polymerase in a position-independent fash- 
ion. This fragment, however, did not induce DNase I hyper- 
sensitivity within the enhancer and did not induce DNase 
I hypersensitivity or T7 accessibility at a distance of 1 kb 
from the enhancer. These results demonstrate that the 
intronic enhancer is sufficient for inducing specific local 
chromatin alterations, but both the enhancer and MARS 
are needed for long-range alterations. In addition, the re- 
sults suggest that the T7 assay measures a more subtle 
chromatin change than does the DNase I assay, implying 
that multiple specific levels of chromatin alterations are 
needed for complete locus accessibility. 
The precise protein-DNA and protein-protein interac- 
tions responsible for the above results are not known. 
However, a model that is consistent with the known facts 
is as follows: in the inaccessible chromatin, one or more 
cell type-specific proteins (e.g., PU.1, Ets-1, or an E2A 
homodimer) may be capable of binding to control elements 
within the 95 bp enhancer fragment. This interaction may 
impart a local chromatin alteration, making the enhancer 
accessible to other cell type-specific and ubiquitous DNA- 
binding proteins (and accessible to T7 RNA polymerase 
in the Jenuwein et al. [1993] assay). The formation of a 
stable protein-DNA complex over the entire 220 bp en- 
hancer may alter chromatin structure more severely (and 
induce DNase I hypersensitivity). The MARS then appear 
to be responsible for propagating the chromatin alterations 
throughout the locus, allowing for efficient transcription 
initiation from the Vn promoter. The mechanism of action 
of the MARS remains unknown, but may involve MAR- 
binding proteins like topoisomerase II, SATBl, or NFu-NR 
(Gasser and Laemmli, 1987; Dickinson et al., 1992; Scheuer- 
mann and Chen, 1989). 
For the most part, the results found in transgenic ani- 
mals are consistent with results found using stable or tran- 
sient transfection assays. However, with the transfection 
assays, the core enhancer imparts strong transcriptional 
enhancement in the absence of the MARS (e.g., Gilles et 
al., 1983; Banerji et al., 1983). Thus, introduction of the 
gene into the germline appears to be critical for establish- 
ing the chromatin configuration that requires the en- 
hancer-MAR combination for disruption. Forrester et al. 
(1994) suggest that DNA methylation may be responsible 
for the differences between the transfection and germline 
transformation assays, as the germline lgfr transgenes 
most likely are methylated prior to transcriptional activa- 
tion during B cell development (Jahner et al., 1982). 
These results highlight the current difficulties in distin- 
guishing between the functions and properties of en- 
hancers, LCRs, MARS, and insulators. Enhancers gener- 
ally are capable of increasing gene transcription in 
transient and stable transfection assays. LCRs provide 
position-independent transcriptional enhancement in 
transgenic mice by increasing locus accessibility. MARS 
provide attachment sites to the nuclear matrix and, in 
some instances, are thought to define chromosomal 
boundaries by insulating a locus from adjacent loci. The 
intronic control regions within the lgp locus do not match 
these general definitions. The MARS are within the locus 
and therefore are unlikely to function as a boundary or 
insulator element. Instead, the MARS appear to function 
in combination with the enhancer as an LCR. Finally, a 
95 bp fragment of the intronic enhancer appears to be 
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sufficient for inducing a position-independent local chro- 
matin alteration, a novel property for an enhancer. The 
ambiguities betweenenhancers, LCRs, MARS, and insula- 
tor highlight the need for further experiments to determine 
whether precise properties can be assigned to each of 
these regulatory regions or whether they comprise a wide 
range of overlapping functions, depending on their precise 
components and proximities to other control regions. 
Concluding Remarks 
The studies described above demonstrate that numerous 
proteins, which carry out a complex array of protein-pro- 
tein and protein-DNA interactions, are required for appro- 
priate lgp regulation. Despite this complexity, the experi- 
ments suggest that either the OCA-B coactivator, the E2A 
homodimer, or the Ets-1IPU.l combination is sufficient for 
imparting considerable B cell specificity to lgp transcrip- 
tion. This suggestion immediately leads to the question 
of why three different strategies are needed for a single 
B cell-specific gene. A partial, if not complete, answer 
to this question is provided by the combinatorial theory. 
Perhaps, each of the three mechanisms only leads to par- 
tial cell type specificity (e.g., E2A homodimers may aCtU- 
ally function in a few non-B cell types, where they may 
regulate an unrelated set of genes). Instead, all three 
mechanisms may need to be combined to achieve the 
precise expression pattern observed with the endogenous 
lgb gene. It may be worth reiterating that the endogenous 
murine lgcl gene and lgb transgenes, despite their com- 
plex regulatory regions, are not perfectly B cell-specific, 
since weak transcription has been detected in several 
other tissues (Jenuwein and Grosschedl, 1991). The wide- 
spread “leakiness” may result from expression of OCA-B 
or E2A homodimers in a few non-B cell tissues, from the 
absence of ZEB or a ZEB-like repressor in other tissues, 
and from the combined expression of PU.l and Ets-1 in 
yet other tissues; possibly, B cells are unique only in that all 
of these mechanisms function simultaneously to efficiently 
activate lgp transcription. An alternative explanation for 
the leakiness is that inappropriate members of the relevant 
transcription factor families (the POU, bHLH, and Ets fami- 
lies) may be capable of functionally interacting with the p 
regulatory elements with low efficiency. In either case, 
the important observation is that the desired expression 
pattern is not absolutely attained, despite the fact that 
numerous proteins and multiple distinct strategies contrib- 
ute to lgp regulation. Given this fact, it might be expected 
that most genes will depend on a similarly complex set of 
proteins and regulatory strategies in attempting to achieve 
an appropriate pattern of expression. 
In light of the studies reviewed in this article, it might 
be valuable to conclude by considering the progress of 
the eukaryotic transcription field through the past 10 years. 
The second half of the 1980s witnessed an explosion in 
the delineation of cis-acting control elements required for 
appropriate regulation of tissue-specific genes, and in the 
identification of trans-acting factors that bind to those con- 
trol elements. At that time, many molecular biologists an- 
ticipated that the straightforward approach, of control ele- 
ment to DNA-binding protein to DNA-binding protein gene, 
would rapidly lead to an understanding of the mechanisl 
by which numerous genes are regulated. However, 
more and more control regions and transcription facts 
were characterized, several results revealed that tri 
scriptional regulatory mechanisms would be extremely ( 
ficult to dissect: Numerous cis-acting control elemel 
were often needed for appropriate regulation of a giu 
gene; transcription factors rarely mimicked the precise I 
pression patterns of their putative target genes; multi1 
members of a transcription factor family typically were I 
pable of binding to a given control element; DNA fri 
ments containing the promoter and enhancers for a gh 
gene were insufficient for appropriate regulation in tra 
genie mice; and transcriptional activators were incapa 
of stimulating transcription by the general transcript 
factors in the absence of additional coactivators. Althoi 
many of these findings were predicted by the combim 
rial principles that were proposed 20 years earlier (Giel 
1973; Britten and Davidson, 1969; Georgiev, 1969), 
degree of complexity was nearly overwhelming. 
The experiments and concepts described here rev 
that tremendous progress has been made in the first t 
of the 1990s in furthering our understanding of the met 
nisms of transcriptional control. For the most part, 1 
progress can be attributed to the increased use of gt 
knockout technology, as well as to three advanced 
proaches to the study of regulated transcription. The f 
approach has been to study control elements in the c 
text of a natural promoter or enhancer, rather than indC 
ually. This strategy, which is exemplified by the stud 
of repression through the wE5 element and of actival 
through the CIA-~E~-~B region, clearly is leading tl 
more accurate picture of the protein-DNA and prote 
protein interactions needed for appropriate regulati 
The second advanced approach has been to emplo! 
vitro transcription assays reconstituted with highly puril 
or recombinant proteins for the study of ‘transcriptic 
activation and repression. These studies, which are sic 
by powerful genetic approaches in Saccharomyces c( 
visiae, have facilitated the identification of coactival 
and have led to rapid advances towards an understanc 
of the precise mechanisms by which regulatory prott 
modulate the frequency of transcription initiation by 
II. The third approach has been to apply more inten! 
efforts towards studying the mechanisms through wt 
genes are regulated in the context of an intact chroi 
some, by analyzing the roles of chromatin proteins ; 
of specialized control elements like insulators, silencl 
LCRs, and MARS. Continuing efforts in each of these th 
directions will certainly lead to further advances in 
second half of the decade. Eventually, these advan 
may allow us to determine whether the complex regula 
schemes that have been observed rely on a relatively 
predictable combination of differentially expressed t 
scription factors or an intricate network of regulatory 
tors arranged in a rational hierarchical order. 
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